Description

Nolvadex (tamoxifen) is a nonsteroidal selective estrogen receptor modulator (SERM) that has both estrogen agonist and estrogen antagonist properties in different parts of the body. Nolvadex belongs to a group of compounds called triphenylethylene compounds, including Clomid (clomiphene citrate) and a compound closely related to Nolvadex.

It is most often used during a cycle to remove and reverse the formulation of gynecomastia in the early stages and is most popular as part of post cycle therapy. Normally 20 to 40 mg of Nolvadex is given daily for about 4 to 6 weeks.

Tamoxifen is an effective hormone therapy used to treat hormone receptor positive breast cancer. It can greatly reduce the risk of cancer recurrence and invasive cancer. Some people take tamoxifen to reduce the risk of breast cancer. Daily oral administration of drugs prevents cancer cells from using estrogen and progesterone for growth and spread.

See info about Clomid PCT

EXHIBITION AND ACCESS

What is tamoxifen?

Tamoxifen (Nolvadex® or Soltamox®) is a drug that treats hormone-positive (hormone-positive) breast cancer. It can also help prevent breast cancer. Since tamoxifen was approved by the Food and Drug Administration (FDA) in 1998, it has become one of the most widely used treatments for breast cancer.

What is hormone receptor positive breast cancer?

Hormone receptor positive breast cancer tumors need the hormones estrogen or progesterone (or sometimes both) to grow. About 75% of breast cancers are hormone-positive in postmenopausal patients. Your healthcare professional will perform a biopsy and lab tests to determine the type of cancer and the most effective treatment.

How does tamoxifen work?

Tamoxifen is a type of hormone therapy called a selective estrogen receptor modulator (SERM). The drug binds to hormone receptors (specific proteins) in breast cancer cells. Once inside the cells, the medicine blocks the cancer from accessing the hormones it needs to multiply and grow.